Table: Sapporo Clinical Lab -2024/25 group results

Sapporo Clinical Laboratory

12/05/2025 07:35

May 12 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           20.13           19.68          20.69        10.31    
               (+2.3 pct)      (-2.2 pct)     (+2.8 pct)    (+3.2 pct) 
  Operating      706 mln         534 mln        775 mln      366 mln   
               (+32.1 pct)     (-47.0 pct)    (+9.9 pct)    (+8.6 pct) 
  Recurring      707 mln         514 mln        771 mln      365 mln   
               (+37.5 pct)     (-55.6 pct)    (+8.9 pct)    (+6.6 pct) 
  Net
  Net            464 mln         380 mln        505 mln      238 mln   
               (+22.1 pct)     (-33.1 pct)    (+9.0 pct)    (+7.3 pct) 
  EPS          148.35 yen      114.14 yen     163.43 yen    76.37 yen  
  Ann Div       23.00 yen       23.00 yen      23.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       23.00 yen       23.00 yen      23.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T